Genaphed and Trumenba

• Generic Name: pseudoephedrine
• Dosage Forms: n.a.
• Other Brand Names: Chlor Trimeton Nasal Decongestant, Contac Cold, Drixoral Decongestant Non-Drowsy, Elixsure Decongestant, Genaphed, Nasofed, Nexafed, Silfedrine, Sudafed, Sudafed Children's Nasal Decongestant, SudoGest, Suphedrin, Triaminic Softchews Allergy Congestion, Entex, Kid Kare Drops, Seudotabs, Sudafed 12-Hour, Sudafed 24-Hour, Sudodrin, SudoGest 12 Hour, Unifed, Decongestant 12Hour Max St, Shopko Nasal Decongestant, Sudafed 12 Hour, Sudafed 24 Hour, Nasal Decongestant, Psudatabs, Shopko Nasal Decongestant Max, Simply Stuffy, Suphedrine, Zephrex-D

Genaphed is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).

Genaphed is used to treat nasal and sinus congestion, or congestion of the tubes that drain fluid from your inner ears, called the eustachian (yoo-STAY-shun) tubes.

Genaphed may also be used for purposes not listed in this medication guide.

• Generic Name: meningococcal group B vaccine
• Dosage Forms: n.a.
• Other Brand Names: Bexsero, Trumenba

Meningococcal disease is a serious infection caused by a bacteria. Meningococcal bacteria can infect the spinal cord and brain, causing meningitis that can be fatal. Meningococcal disease can also lead to permanent and disabling medical problems.

Meningococcal disease can spread from one person to another through small droplets of saliva released into the air when an infected person coughs or sneezes. The bacteria can also live on things the infected person has touched, such as a door handle or other surface. The bacteria can also be passed through kissing, or sharing a drinking glass or eating utensil with an infected person.

Meningococcal disease is more likely to occur in babies younger than 1 year, in young people ages 16 to 23 years, in anyone with a weak immune system, and in anyone exposed to an outbreak of the disease.

Trumenba is used to prevent infection caused by serogroup B meningococcal bacteria. This vaccine contains four common strains of group B meningococcal bacteria.

This vaccine works by exposing you to a small dose of the bacteria (or a protein from the bacteria), which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.

Trumenba is for use in children and young adults who are 10 to 25 years old. The Centers for Disease Control recommends that the best time to get this vaccine is between the ages of 16 and 18 years old.

Like any vaccine, the Trumenba may not provide protection from disease in every person.